P

PHIO

PHIO

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
PHIO Live QuoteReal-time
$0.66
$0.21(-24.60%)1M
Day Range$0.64 – $0.74
Open$0.73
Previous Close$0.71
Volume145.4K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$8.55M
P/E Ratio (TTM)24.5
Forward P/E0.3
EPS (TTM)$-1.19
Price to Book1.0
Dividend Yield0.65%
Beta (Volatility)0.92
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $0.66 (1%)
Low: $0.64High: $1.88
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$14.00-90.7% upside

Insider Buys

2

$17K

Insider Sales

0

$0

Total Volume

$17K

2 transactions

Net Activity

+$17K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
75CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
P
1

Plott Ronald Todd

Dir

1 buys0 sells

$10K total

B
2

Bradford Patricia A

Dir

1 buys0 sells

$7K total

Trading History
PHIO insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 28, 2026

1 months ago

Plott Ronald Todd

Dir

Director
Buy10.0K$1.04$10K

Sep 24, 2026

1 months ago

Bradford Patricia A

Dir

Director
Buy6.5K$1.01$7K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
PHIO Buy Conviction100%
Industry Rank#0 of 564
Volume Contribution0.0%
Total Industry Activity$16.46B

PHIO has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for PHIO

Over the last 90 days, corporate insiders at PHIO (PHIO) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 0 were sales. The total volume of insider trading reached $17K.

The net insider activity for PHIO shows a net buying bias of $17K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Plott Ronald Todd (Dir), who traded 10.0K shares valued at $10K on Sep 28, 2026.

Live Market News & Developments
Aggregated real-time headlines for PHIO (PHIO)
6 updates

Phio Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard

TradingView4h ago

IDAI,AMRC,NTHI,PRTS,LIEN,AGMB,RGCO,LRMR,SELF,AN,AIAI,REFI,EQPT,MTDR,GROV,BRID,AFCG,DTI,SRTS,BGDE,WVVI,PHIO,PAM,GME | Stock Prices | Quote Comparison - Yahoo Finance

Yahoo! Finance Canada15h ago

Form 8K Phio Pharmaceuticals Corp For: 20 November By Investing.com

Investing.com Canada4h ago

Phio Pharmaceuticals (PHIO) director Deming bought 12,000 shares for $9,823 at an average $0.82

Quantisnow4d ago

PHIO - Phio Pharmaceuticals Corp Stock Price and Quote

Finviz178d ago

Director David H. Deming buys Phio Pharmaceuticals (PHIO) shares in two purchases.

Stock Titan4d ago

FAQs About PHIO Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for PHIO.

Based on SEC Form 4 disclosures, the Insider Confidence Score for PHIO is currently 75/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 2 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for PHIO is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.